BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $4.07 | Prev. Close $4.24 | Circuit Range N/A |
Day Range $4.02 - $4.11 | Year Range $0.61 - $13.78 | Volume 1,814 |
Average Traded $4.07 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-26 | $4.07 | $4.07 | +0.00% |
12-May-26 | $4.07 | $4.07 | -1.57% |
11-May-26 | $4.25 | $4.13 | -0.60% |
08-May-26 | $4.09 | $4.16 | +1.49% |
07-May-26 | $4.14 | $4.09 | -0.63% |
06-May-26 | $4.03 | $4.12 | +1.98% |
05-May-26 | $4.04 | $4.04 | -1.46% |